Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1998;32:243-248

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Heise, T.
Right arrow Articles by Sawicki, P. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Heise, T.
Right arrow Articles by Sawicki, P. T.

(Hypertension. 1998;32:243-248.)
© 1998 American Heart Association, Inc.


Scientific Contributions

Insulin Resistance and the Effect of Insulin on Blood Pressure in Essential Hypertension

Tim Heise; Kai Magnusson; Lutz Heinemann; ; Peter T. Sawicki

From the Department of Metabolic Diseases and Nutrition, Heinrich-Heine University, Düsseldorf, Germany (WHO Collaborating Center for Diabetes).

Abstract—The aim of this study was to investigate the effect of 2 weeks of insulin administration on blood pressure and to simultaneously measure insulin sensitivity and insulin-induced vasodilatation in obese hypertensive patients. In a prospective, randomized, double-blind, crossover study (study 1), 23 obese, untreated, nondiabetic, hypertensive patients received either neutral protamine Hagedorn (NPH) insulin (0.3 U/kg body wt per day) or placebo subcutaneously for 2 weeks (washout period, 2 weeks). Office and 24-hour blood pressure values were measured at the beginning and end of each treatment period. In an open-label study (study 2), 8 obese hypertensive patients and 10 healthy control subjects underwent a 3-step hyperinsulinemic, euglycemic glucose clamp (step 1, 0.5; step 2, 2.5; step 3, 5.0 mU · kg-1 · min-1 [120 minutes each]). Leg blood flow (LBF) was measured by venous occlusion plethysmography. Insulin administration decreased mean±SD office blood pressure from 131±13 to 128±12 mm Hg (placebo, 132±13 and 132±13 mm Hg; P<0.05 between final examinations) and mean±SD 24-hour blood pressure by -3.3±6.9 mm Hg (placebo, +0.7±4.6 mm Hg; P<0.05). Insulin infusion increased LBF significantly in the healthy controls but not in obese insulin-resistant hypertensive subjects. Obese hypertensive patients are resistant to the effects of insulin with regard to both glucose uptake and vasodilatation. Administration of insulin exerts a small blood pressure–lowering effect in these patients. These data strongly argue against the postulated pressor action of insulin in essential hypertension.


Key Words: insulin • insulin resistance • hypertension, essential • blood flow • vasodilation




This article has been cited by other articles:


Home page
Endocr. Rev.Home page
R. Muniyappa, M. Montagnani, K. K. Koh, and M. J. Quon
Cardiovascular Actions of Insulin
Endocr. Rev., August 1, 2007; 28(5): 463 - 491.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. F. Saad, M. Rewers, J. Selby, G. Howard, S. Jinagouda, S. Fahmi, D. Zaccaro, R. N. Bergman, P. J. Savage, and S. M. Haffner
Insulin Resistance and Hypertension: The Insulin Resistance Atherosclerosis Study
Hypertension, June 1, 2004; 43(6): 1324 - 1331.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M.-S. Tan, S.-Y. Chang, D.-M. Chang, J. C.-R. Tsai, and Y.-J. Lee
Association of Resistin Gene 3'-Untranslated Region +62G->A Polymorphism with Type 2 Diabetes and Hypertension in a Chinese Population
J. Clin. Endocrinol. Metab., March 1, 2003; 88(3): 1258 - 1263.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
D. C. Goff Jr, D. J. Zaccaro, S. M. Haffner, and M. F. Saad
Insulin Sensitivity and the Risk of Incident Hypertension: Insights from the Insulin Resistance Atherosclerosis Study
Diabetes Care, March 1, 2003; 26(3): 805 - 809.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Hypertension, Insulin, and Proinsulin in Participants With Impaired Glucose Tolerance
Hypertension, November 1, 2002; 40(5): 679 - 686.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
E. H Serne, R. O.B Gans, J. C ter Maaten, P. M ter Wee, A. J.M Donker, and C. D.A Stehouwer
Capillary recruitment is impaired in essential hypertension and relates to insulin's metabolic and vascular actions
Cardiovasc Res, January 1, 2001; 49(1): 161 - 168.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
B. Falkner, K. Sherif, A. E. Sumner, and H. Kushner
Blood Pressure Increase With Impaired Glucose Tolerance in Young Adult American Blacks
Hypertension, November 1, 1999; 34(5): 1086 - 1090.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
P. F. Damiano, M. I. Roson, I. Armando, S. Nowicki, E. Dascal, L. Cuniberti, L. E. Albornoz, and Ignacio J. de la Riva ;
Potential Role of Glycerol Leading to Rat Fructose Hypertension
Hypertension, October 1, 1999; 34(4): 1007 - 1011.
[Abstract] [Full Text] [PDF]